PRSS38
Serine protease 38
Also known as: MPN2, PRS38_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A1L453
- Gene
- PRSS38
- Ensembl
- ENSG00000185888
- Chromosome
- 1
- Canonical length
- 326 aa
- Protein class
- Enzymes, Predicted secreted proteins
- Secretome location
- Secreted in male reproductive system
OverviewNCBI Gene
Predicted to enable serine-type endopeptidase activity. Predicted to be involved in proteolysis. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
326 residues, UniProt reviewed canonical sequence.
>A1L453|PRSS38
1 MAAPASVMGP LGPSALGLLL LLLVVAPPRV AALVHRQPEN QGISLTGSVA CGRPSMEGKI
61 LGGVPAPERK WPWQVSVHYA GLHVCGGSIL NEYWVLSAAH CFHRDKNIKI YDMYVGLVNL
121 RVAGNHTQWY EVNRVILHPT YEMYHPIGGD VALVQLKTRI VFSESVLPVC LATPEVNLTS
181 ANCWATGWGL VSKQGETSDE LQEMQLPLIL EPWCHLLYGH MSYIMPDMLC AGDILNAKTV
241 CEGDSGGPLV CEFNRSWLQI GIVSWGRGCS NPLYPGVYAS VSYFSKWICD NIEITPTPAQ
301 PAPALSPALG PTLSVLMAML AGWSVLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRSS38 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 4.1 nTPM
Expression across tissuesHPA
Tissue
- testis: 4.1 nTPM
- choroid plexus: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
- appendix: 0 nTPM
Single-cell type
- early primary spermatocytes: 47 nCPM
- differentiating spermatogonia: 11 nCPM
- medullary thymic epithelial cells: 9.6 nCPM
- epicardial cells: 4.5 nCPM
- retinal ganglion cells: 3.9 nCPM
- epididymal basal cells: 2.8 nCPM
Immune cell
- NK-cell: 0.4 nTPM
- gdT-cell: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- basal ganglia: 0.3 nTPM
- cerebral cortex: 0.3 nTPM
- medulla oblongata: 0.3 nTPM
- pons: 0.3 nTPM
- cerebellum: 0.2 nTPM
- spinal cord: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.22
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.08
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRSS38 as an antibody target. Whether an autoantibody or antibody against PRSS38 could matter depends on whether native PRSS38 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRSS38 is annotated as secreted, so native PRSS38 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PRSS38 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...